NVCR icon

NovoCure (NVCR)

NAS

$17.85

$0.96 (

+5.68%

)

1D
5D
1M
6M
1Y
5Y
Market closed

NVCR: $17.85 / ₿ 0.0002 BTC / 16404 Sats

11:53 AM03:12 PM04:55 PM06:35 PM$16.84$16.99$17.14$17.29$17.44$17.72
1D
5D
1M
6M
1Y
5Y

Last updated July 8th, 2025 at 9:21PM. Log in now to access real-time pricing data.

Key statistics

$16.89
$14.17 - $34.13
$1.99B
3.25
$17.18
$1,383,002.00
111.49M
$17.22 - $17.85
$16.91 - $17.66
Yes

What is NovoCure (NVCR)?

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

The NovoCure (NVCR) stock price has been rising

The NovoCure Limited Ordinary Shares (NVCR) stock price today is $17.85, reflecting a +5.68% move since the market opened. The company’s market capitalization stands at $1.99B, with a daily trading volume of $1.38M shares. For investors tracking price trends, NovoCure Limited Ordinary Shares stock has ranged between $16.91 and $17.66 today. The previous closing price was $16.89.

How to buy NovoCure (NVCR)

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy NVCR

Search for NVCR in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy NVCR.

NVCR FAQs

NVCR is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

NVCR is in the Medical Devices industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, NovoCure Limited Ordinary Shares (NVCR) has traded between a low of $14.17 and a high of $34.13.

NVCR is in the Medical Devices & Instruments industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in NovoCure? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
NVCR icon
NVCR

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy NovoCure in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

PHH icon
PITEF icon
BHILQ icon

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.